New incident report
Incident Report Number: 2008-1026
Registrant Reference Number: 273363
Registrant Name (Full Legal Name no abbreviations): Bell Laboratories, Inc.
Address: 3699 Kinsman Blvd
City: Madison
Prov / State: WI
Country: USA
Postal Code: 53704
Domestic Animal
Country: UNITED STATES
Prov / State: OHIO
PMRA Registration No. PMRA Submission No. EPA Registration No.
Product Name: Tomcat Rat + Mouse Bait
Bait
Yes
Unknown
Site: Res. - In Home / Rés. - à l'int. maison
Animal's Owner
Dog / Chien
Labrador Retriever
1
Male
10
100.00
lbs
Oral
<=15 min / <=15 min
>2 hrs <=8 hrs / > 2 h < = 8 h
System
Persisted until death
No
No
Died
Other / Autre
specify Unconfirmed exposure
(eg. description of the frequency and severity of the symptoms
12/24/2007 1:01:21 PMThe caller admits to spreading the product throughout his barn (tossing the pellets into stalls and placing them under stall mats) within the past 1-2 days. During this time, he suspects his dog may have ingested a very small amt (less than 60 pellets). He is calling to report that his dog vomited a milky colored substance, is acting lethargic, and seems unable to walk. He firmly denies that the dog could have had any access to the product more than 24 hours prior to this call and denies the use of any other products on his farm in recent days. The caller did contact his veterinarian and was told to bring the dog into the clinic the following morning. The dog died at home during the night and the caller reports seeing a small amount of bleeding around the dog¿s gums just prior to death. The body was buried on-site; no diagnostic testing, medical evaluation, or necropsy was performed.
Death
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.